Skip to content
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
EN
SV
Press releases
Category
All
Regulatory
Non-Regulatory
Interim
Annual
Year
All
2025
2024
2023
2022
2023
2023-11-28 13:40
BioStock publishes article about Prolight Diagnostics
2023-11-27 15:05
Prolight Diagnostics publishes quarterly report Q3, 2023
Regulatory
MAR
2023-11-27 12:45
Extraordinary general meeting of Prolight Diagnostics AB (publ) on 27 November 2023
Regulatory
2023-11-24 08:00
Prolight Diagnostics achieves ISO 13485 accreditation
Regulatory
2023-11-23 08:00
Prolight Diagnostics shows proof of performance in whole blood
Regulatory
2023-11-13 12:00
TTP evolves MicroFlex technology
2023-10-26 08:45
Notice of extraordinary general meeting in Prolight Diagnostics AB (publ)
Regulatory
2023-10-26 08:30
The Board of Directors of Prolight Diagnostics AB (publ) resolves on a rights issue of units of approximately SEK 98.8 million and proposes a directed issue of shares of approximately SEK 20.9 million
Regulatory
MAR
2023-10-09 08:00
Prolight Diagnostics forms Clinical Advisory Board
2023-10-02 08:00
Prolight Diagnostics publishes investor letter for October 2023
Regulatory
Previous
Next